Published in Cancer Weekly, December 11th, 2007
The expertise within the group closely matches Premier Research's focus on clinical research services in neuroscience, analgesia, oncology, infectious disease, and pediatrics. It also reflects the firm's strength in medical device development, adaptive clinical trials design, and state of the art clinical trial related technologies.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.